Compound Info
NAs Base Info
ID Cluster Name Target MolWt
Compound Structure
NAs.002027 2
Target name Tax id
Phosphoribosyl pyrophosphate synthetase-associated protein 2
Adenosine deaminase
602.398
Chemical Representations
InChI InChI=1S/C18H24N10O10P2/c19-14-10-17(24-5-21-14)28(7-25-10)18-12(29)13(9(37-18)3-36-40(32,33)34)38-39(30,31)8-35-2-1-27-6-26-16-11(27)15(20)22-4-23-16/h4-7,9,12-13,18,29H,1-3,8H2,(H,30,31)(H2,19,21,24)(H2,20,22,23)(H2,32,33,34)/t9-,12-,13-,18-/m1/s1
InChI Key HZMBALOCWYVVPP-ACDAHVMNSA-N
SMILES Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)COCCn2cnc3ncnc(N)c32)[C@H]1O
Molecular Formula C18H24N10O10P2
Functional Fragments
Base Ribose Phosphate
Base Structure
Match
 No Image Available
Match
Calculated Properties
logP -1.257 Computed by RDKit
Heavy Atom Count 40 Computed by RDKit
Ring Count 5 Computed by RDKit
Hydrogen Bond Acceptor Count 17 Computed by RDKit
Hydrogen Bond Donor Count 6 Computed by RDKit
Rotatable Bond Count 11 Computed by RDKit
Topological Polar Surface Area 291.220 Computed by RDKit
Activity Data
Target Activity type Relation Value Unit Assay Source
Adenosine deaminase Km = 160000.0 nM Michaelis rate constant is determined by the Lineweaver and Burk method against adenosine deaminase CHEMBL1134666
Adenosine deaminase Relative Vmax = 9.8 Maximum velocity constant of the rate of deamination was determined against adenosine deaminase CHEMBL1134666
Adenosine deaminase Ki = 100000.0 nM Inhibitory activity against adenosine deaminase CHEMBL1134666
Phosphoribosyl pyrophosphate synthetase-associated protein 2 Km = 570000.0 nM Michaelis rate constant is determined by the Lineweaver and Burk method against PRPP synthetase CHEMBL1134666
Phosphoribosyl pyrophosphate synthetase-associated protein 2 Relative Vmax = 12.0 Maximum velocity constant of the rate of phosphorylation was determined against PRPP synthetase CHEMBL1134666
Phosphoribosyl pyrophosphate synthetase-associated protein 2 Ki = 790000.0 nM Inhibitory activity against PRPP synthetase CHEMBL1134666
Human immunodeficiency virus 1 IC50 = 5.9 ug.mL-1 Inhibition of cytopathogenicity against human HIV-1(IIIB) in MT-4 cells CHEMBL1134666
Human immunodeficiency virus 2 IC50 = 6.4 ug.mL-1 Inhibition of cytopathogenicity against human HIV-2(LAV-2) in MT-4 cells CHEMBL1134666
Moloney murine sarcoma virus IC50 = 17.0 ug.mL-1 Inhibition of antiviral activity against moloney murine sarcoma virus(MSV)in CEM cells in cell protection assay CHEMBL1134666
MT4 IC50 = 298.0 ug.mL-1 Cellular toxic effect was determined in MT-4 cells CHEMBL1134666
CCRF-CEM IC50 > 300.0 ug.mL-1 Cellular toxic effect was determined in CEM cells CHEMBL1134666
Unchecked Symptom initiation > 21.0 % Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 250 mk/kg/day CHEMBL1134666
Unchecked Symptom initiation = 19.3 % Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 150 mk/kg/day CHEMBL1134666
Unchecked Symptom initiation = 16.0 % Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 100 mk/kg/day CHEMBL1134666
Unchecked Animal death > 21.0 % Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 250 mk/kg/day CHEMBL1134666
Unchecked Animal death = 19.5 % Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 150 mk/kg/day CHEMBL1134666
Unchecked Animal death > 21.0 % Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 100 mk/kg/day CHEMBL1134666